Alcohol consumption and persistent infection of high-risk human papillomavirus

Epidemiology and Infection

Volumn 143, Issue 7, 2015, Pages 1442-1450

  Oh, H Y ^a   Kim, M K ^a   Seo, S ^a   Lee, D O ^a   Chung, Y K ^a   Lim, M C ^a   Kim, J ^a   Lee, C W ^a   Park, S ^a  

^a National Cancer Center   (South Korea)

Author keywords

Alcohol; cervical carcinogenesis; co factors; human papillomavirus; persistence

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ARTICLE; BEER; CONTROLLED STUDY; DISEASE ASSOCIATION; DRINKING BEHAVIOR; FEMALE; HIGH RISK POPULATION; HUMAN; INFECTION RISK; KOREA; PAPILLOMAVIRUS INFECTION; PERSISTENT VIRUS INFECTION; PROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING; SOJU; UTERINE CERVICITIS; WOMEN'S HEALTH; AGED; INCIDENCE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHYSIOLOGY; RISK; RISK FACTOR; SOUTH KOREA; STATISTICAL MODEL; VIROLOGY;

ADULT; AGED; ALCOHOL DRINKING; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RISK FACTORS;

EID: 84926345350     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268814002258     Document Type: Article

References (41)

1. Schiffman MH, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. Journal of the National Cancer Institute 1993; 85: 958-964.
2. Ho GY, et al. Natural history of cervicovaginal papillomavirus infection in young women. New England Journal of Medicine 1998; 338: 423-428.
3. Schiffman M, et al. Human papillomavirus and cervical cancer. Lancet 2007; 370: 890-907.
4. de Freitas AC, et al. Susceptibility to cervical cancer: an overview. Gynecologic Oncology 2012; 126: 304-311.
5. de Araujo Souza PS, Sichero L, Maciag PC. HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer. Future Oncology (London, England) 2009; 5: 359-370.
6. Lai CH, et al. Host and viral factors in relation to clearance of human papillomavirus infection: a cohort study in Taiwan. International Journal of Cancer 2008; 123: 1685-1692.
7. Schmeink CE, et al. Human papillomavirus persistence in young unscreened women, a prospective cohort study. PLoS ONE 2011; 6: e27937.
8. Hibma MH. The immune response to papillomavirus during infection persistence and regression. Open Virology Journal 2012; 6: 241-248.
9. Nielsen A, et al. Persistence of high-risk human papillomavirus infection in a population-based cohort of Danish women. Journal of Medical Virology 2010; 82: 616-623.
10. Anon. IARC monographs on the evaluation of carcinogenic risks to humans: Alcohol consumption and ethyl carbamate. Lyon, France: WHO, IARC; 20101017-1606 (print), 1017-1606 (linking) (series 2010/01/01).
11. Rod NH, et al. Low-risk factor profile, estrogen levels, and breast cancer risk among postmenopausal women. International Journal of Cancer 2009; 124: 1935-1940.
12. Hjartaker A, Meo MS, Weiderpass E. Alcohol and gynecological cancers: an overview. European Journal of Cancer Prevention 2010; 19: 1-10.
13. Goodman MT, et al. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Research 2008; 68: 8813-8824.
14. Solomon D, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. Journal of the American Medical Association 2002; 287: 2114-2119.
15. Sigvardsson S, et al. Increased cancer risk among Swedish female alcoholics. Epidemiology 1996; 7: 140-143.
16. Weiderpass E, et al. Alcoholism and risk for cancer of the cervix uteri, vagina, and vulva. Cancer Epidemiology, Biomarkers and Prevention 2001; 10: 899-901.
17. Adami HO, et al. Alcoholism and cancer risk: a population-based cohort study. Cancer Causes and Control 1992; 3: 419-425.
18. Allen NE, et al. Moderate alcohol intake and cancer incidence in women. Journal of the National Cancer Institute 2009; 101: 296-305.
19. Kim MK, Ko MJ, Han JT. Alcohol consumption and mortality from all-cause and cancers among 1·34 million Koreans: the results from the Korea national health insurance corporation's health examinee cohort in 2000. Cancer Causes and Control 2010; 21: 2295-2302.
20. Nova E, et al. Potential health benefits of moderate alcohol consumption: current perspectives in research. Proceedings of the Nutrition Society 2012; 71: 307-315.
21. Jin M, et al. Alcohol drinking and all cancer mortality: a meta-analysis. Annals of Oncology 2013; 24: 807-816.
22. Druesne-Pecollo N, et al. Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncology 2009; 10: 173-180.
23. Baraona E, et al. Gender differences in pharmacokinetics of alcohol. Alcoholism, Clinical and Experimental Research 2001; 25: 502-507.
24. Sanjoaquin MA, et al. Folate intake and colorectal cancer risk: a meta-analytical approach. International Journal of Cancer 2005; 113: 825-828.
25. Powers HJ. Interaction among folate, riboflavin, genotype, and cancer, with reference to colorectal and cervical cancer. Journal of Nutrition 2005; 135 (12 Suppl.): 2960S-2966S.
26. Piyathilake CJ, et al. Indian women with higher serum concentrations of folate and vitamin B12 are significantly less likely to be infected with carcinogenic or highrisk (HR) types of human papillomaviruses (HPVs). International Journal of Women's Health 2010; 2: 7-12.
27. Ferguson AW, Svoboda-Newman SM, Frank TS. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Modern Pathology 1998; 11: 11-18.
28. Poschl G, et al. Alcohol and cancer: genetic and nutritional aspects. Proceedings of the Nutrition Society 2004; 63: 65-71.
29. De Marco F. Oxidative Stress and HPV Carcinogenesis. Viruses 2013; 5: 708-731.
30. Fernandez C, et al. Evaluation of the significance of polyamines and their oxidases in the aetiology of human cervical carcinoma. British Journal of Cancer 1995; 72: 1194-1199.
31. Siegel EM, et al. Circulating biomarkers of iron storage and clearance of incident human papillomavirus infection. Cancer Epidemiology, Biomarkers and Prevention 2012; 21: 859-865.
32. Einstein MH, et al. Clinician's guide to human papillomavirus immunology: knowns and unknowns. Lancet Infectious Diseases 2009; 9: 347-356.
33. Anon. Average monthly income and expenditure. Korean Statistical Information Service: Statistics Korea, 2013 (http://kosis.kr/index/index.jsp).
34. Crum RM, et al. The risk of alcohol abuse and dependence in adulthood: the association with educational level. American Journal of Epidemiology 1992; 135: 989-999.
35. Thun MJ, et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. New England Journal of Medicine 1997; 337: 1705-1714.
36. Park YJ, et al. Sexuality and related factors of postmenopausal Korean women. Taehan Kanho Hakhoe chi 2003; 33: 457-463.
37. Yoon H, et al. Questionnaire based evaluation of sexual activity and sexual dysfunction in Korean women. Korean Journal of Urology 2001; 42: 102-114.
38. Gage JC, et al. Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesions. Cancer Epidemiology, Biomarkers & Prevention 2010; 19: 1668-1674.
39. Marks MA, et al. Evaluation of any or type-specific persistence of high-risk human papillomavirus for detecting cervical precancer. Journal of Clinical Microbiology 2012; 50: 300-306.
40. Kim JW, et al. Factors affecting the clearance of high-risk human papillomavirus infection and the progression of cervical intraepithelial neoplasia. Journal of International Medical Research 2012; 40: 486-496.
41. Yoo KY, et al. Risk factors associated with uterine cervical cancer in Korea: a case-control study with special reference to sexual behavior. Journal of Epidemiology 1997; 7: 117-123.